Osteoporosis
Now in its third edition, Osteoporosis, is the most comprehensive, authoritative reference on this disease. Written by renowned experts in the field, this two-volume reference is a must-have for academic and medical libraries, physicians, researchers, and any company involved in osteoporosis research and development. Worldwide, 200 million women between 60-80 suffer from osteoporosis and have a lifetime risk of fracture between 30 and 40 percent continuing to make osteoporosis a hot topic in medicine. This newest edition covers everything from basic anatomy and physiology to diagnosis, management and treatment in a field where direct care costs for osteoporitic fractures in the U.S. reach up to $18 billion each year.NEW TO THIS EDITION:*Recognizes the critical importance of the Wnt signaling pathway for bone health *Incorporates new chapters on osteocytes, phosphatonins, mouse genetics, and CNS and bone *Examines essential updates on estrogen prevention and treatment and the recent results from the WHI *Discusses the controversial topics of screening and clinical trial design for drug registration *Includes essential updates on therapeutic uses of calcium, vitamin D, SERMS, bisphosphonates, and parathyroid hormone * Offers critical reviews of reproductive and hormonal risk factors, ethnicity, nutrition, therapeutics, management, and economics comprising a tremendous wealth of knowledge in a single source not found elsewhere
1116736665
Osteoporosis
Now in its third edition, Osteoporosis, is the most comprehensive, authoritative reference on this disease. Written by renowned experts in the field, this two-volume reference is a must-have for academic and medical libraries, physicians, researchers, and any company involved in osteoporosis research and development. Worldwide, 200 million women between 60-80 suffer from osteoporosis and have a lifetime risk of fracture between 30 and 40 percent continuing to make osteoporosis a hot topic in medicine. This newest edition covers everything from basic anatomy and physiology to diagnosis, management and treatment in a field where direct care costs for osteoporitic fractures in the U.S. reach up to $18 billion each year.NEW TO THIS EDITION:*Recognizes the critical importance of the Wnt signaling pathway for bone health *Incorporates new chapters on osteocytes, phosphatonins, mouse genetics, and CNS and bone *Examines essential updates on estrogen prevention and treatment and the recent results from the WHI *Discusses the controversial topics of screening and clinical trial design for drug registration *Includes essential updates on therapeutic uses of calcium, vitamin D, SERMS, bisphosphonates, and parathyroid hormone * Offers critical reviews of reproductive and hormonal risk factors, ethnicity, nutrition, therapeutics, management, and economics comprising a tremendous wealth of knowledge in a single source not found elsewhere
475.0 In Stock

eBook

$475.00 

Available on Compatible NOOK devices, the free NOOK App and in My Digital Library.
WANT A NOOK?  Explore Now

Related collections and offers


Overview

Now in its third edition, Osteoporosis, is the most comprehensive, authoritative reference on this disease. Written by renowned experts in the field, this two-volume reference is a must-have for academic and medical libraries, physicians, researchers, and any company involved in osteoporosis research and development. Worldwide, 200 million women between 60-80 suffer from osteoporosis and have a lifetime risk of fracture between 30 and 40 percent continuing to make osteoporosis a hot topic in medicine. This newest edition covers everything from basic anatomy and physiology to diagnosis, management and treatment in a field where direct care costs for osteoporitic fractures in the U.S. reach up to $18 billion each year.NEW TO THIS EDITION:*Recognizes the critical importance of the Wnt signaling pathway for bone health *Incorporates new chapters on osteocytes, phosphatonins, mouse genetics, and CNS and bone *Examines essential updates on estrogen prevention and treatment and the recent results from the WHI *Discusses the controversial topics of screening and clinical trial design for drug registration *Includes essential updates on therapeutic uses of calcium, vitamin D, SERMS, bisphosphonates, and parathyroid hormone * Offers critical reviews of reproductive and hormonal risk factors, ethnicity, nutrition, therapeutics, management, and economics comprising a tremendous wealth of knowledge in a single source not found elsewhere

Product Details

ISBN-13: 9780080553474
Publisher: Elsevier Science & Technology Books
Publication date: 11/08/2007
Sold by: Barnes & Noble
Format: eBook
Pages: 2016
File size: 45 MB
Note: This product may take a few minutes to download.

About the Author

Dr. Marcus is Professor-Emeritus, Stanford University, where he served on the full-time medical faculty for almost 25 years, before joining the Emeritus faculty in 2001. At Stanford, he was located at the Veterans Affairs Medical Center, Palo Alto California, where he served as Director of the Aging Study Unit of the Geriatrics Research, Education, & Clinical Center from 1982-2001. Dr. Marcus enjoyed a long career as a clinical investigator in the fields of bone and mineral metabolism and osteoporosis medicine. His own research interests included diagnosis and therapy of primary hyperpara-thyroidism, interactions of the parathyroid-vitamin D axis with estrogen, age-related changes in the growth hormone-IGF axis, effects of growth hormone replacement for older men and women, metabolic and musculoskeletal effects of resistance exercise in older men and women, adolescent bone acquisition, and osteoporosis therapeutics. Dr. Marcus’ laboratory was a study site for many of the pivotal clinical trials in the osteoporosis field. These include the NIH Post-menopausal Estrogen/Progestin Interventions Trial (PEPI), Merck’s Fracture Intervention Trial (FIT), Lilly’s Multiple Outcomes of Raloxifene Intervention (MORE), and Lilly’s registration trial of recombinant PTH(1-34) in the treatment of postmenopausal women with osteoporosis. In 2001. Dr. Marcus joined the US Affiliate of Eli Lilly & Company to support Lilly’s program in Osteoporosis and Skeletal Medicine. From 2003 until his retirement from Lilly in 2008, Dr. Marcus was the lead physician for the Forteo team at Lilly. He has published more than 150 research papers, editorials, and reviews. Dr. Marcus served as President of the American Society for Bone & Mineral Research in 2000-2001.
Dr. Rosen is Professor and Senior Scientists at The Jackson Laboratory, Bar Harbor, Maine, where his group studies the role of insulin-like growth factors on bone and the genetics of osteoporosis in inbred strains of mice. In 2007 he joined the Maine Medical Center Research Institute in Scarborough, Maine. He is also the former Director of the Maine Center for Osteoporosis Research and Education, St. Joseph Hospital, Bangor.Dr. Rosen is a Past President of the American Society of Bone and Mineral Research (ASBMR). He served five years as the First Editor in Chief of the Journal of Clinical Densitometry, the official journal for the International Society of Clinical Densitometry, and currently serves as Associate Editor of the Journal of Bone and Mineral Research. His publications exceed 270 manuscripts published in a wide spectrum of clinical and basic science journals.

Table of Contents

IntroductionThe Bone Organ System: Form and FunctionThe Nature of OsteoporosisThe Economics of OsteoporosisReflections on OsteoporosisSkeletal Heterogeneity and the Purposes of Bone Remodeling: Implications for the Understanding of OsteoporosisBasic Science/Bone BiologyOsteoblast BiologyOsteoclast BiologyOsteocytesThe Regulatory Role of Matrix Proteins in Mineralization of BoneDevelopment of the SkeletonMouse Genetics as a Tool to Study Bone Development and PhysiologyParathyroid Hormone and Parathyroid Hormone-Related ProteinVitamin D: Biology, Action, and Clinical ImplicationsRegulation of Bone Cell Function by EstrogensAndrogens and Skeletal Biology: Basic MechanismsPhosphatoninsWnt Signaling in BoneCytokines and Bone RemodelingSkeletal Growth FactorsIntercellular Communication During Bone RemodelingStructural and BiomechanicsSkeletal Development: Mechanical Consequences of Growth, Aging and DiseaseInhibition of Osteoporosis by Biophysical InterventionBiomechanics of Age-Related FracturesBone QualityEpidemiology & Risk FactorsEpidemiologic Methods in Studies of OsteoporosisRace, Ethnicity and OsteoporosisThe Study of Osteoporotic Fractures (SOF): Major Findings and ContributionsBone Mineral Acquisition in Utero and During Infancy and ChildhoodBone Acquisition in Adolescence Genetic Determinants of Osteoporosis Nutrition and Risk for Osteoporosis Physical Activity in Prevention of Osteoporosis and Associated Fractures Premenopausal Reproductive and Hormonal Characteristics and the Risk for Osteoporosis Non-Skeletal Risk Factors for Osteoporosis and Fractures Falls as Risk Factors for Fracture Assessment of Fracture Risk Outcomes of Osteoporotic Fractures PathophysiologyLocal and Systemic Factors in the Pathogenesis of Osteoporosis Animal Models for Osteoporosis Estrogen, Bone Homeostasis and OsteoporosisPostmenopausal Osteoporosis: How the Hormonal Changes of Menopause Cause Bone Loss Osteoporosis in Men: Epidemiology, Pathophysiology, and Clinical Characterization Osteoporosis in Childhood and Adolescence Glucocorticoid-Induced Osteoporosis Adult Scoliosis, Degenerative Disease, and BMD: a Sub-Segmental Analytic Approach Mechanisms of Immobilization-induced Bone Loss Leptin-Dependent Regulation of Bone Mass Thyroid Hormone and the Skeleton Osteoporosis in Gastrointestinal, Pancreatic, and Hepatic Disease The Skeletal Actions of Parathyroid Hormone in Primary Hyperparathyroidism and in Osteoporosis Osteogenesis Imperfecta and Other Defects of Bone Development as Occasional Causes of Adult Osteoporosis Osteoporosis Associated with Illnesses and Medications Transplantation Osteoporosis Osteoporosis Associated with Cancer Therapy Osteoporosis Associated with Pregnancy Osteoporosis Associated with Rheumatologic Disease Oral Bone Loss and Systemic Osteopenia: Potential Treatment and Risks Localized Osteoporosis Evaluation and ManagementEvaluation of the Patient with Osteoporosis or at Risk for Osteoporosis Who Should be Screened: Who Should be Treated? Radiology of Osteoporosis Clinical Use of Bone Densitometry Biochemical Markers of Bone Turnover in Osteoporosis The Conundrum of Compliance and Persistence with Oral Bisphosphonates for Postmenopausal Osteoporosis An Orthopedic Perspective of OsteoporosisLessons from Bone Histomorphometry on the Mechanism of Action of Osteoporosis Drugs Pharmacology and TherapeuticsDesign Considerations for Clinical Investigations of Osteoporosis Regulatory Considerations for the Design and Conduct of Osteoporosis Registration Trials Evidence-Based Osteoporosis Care The Role of Calcium in the Treatment of Osteoporosis Vitamin D and i

What People are Saying About This

From the Publisher

This newest edition covers everything from basic anatomy and physiology to diagnosis, management and treatment.

From the B&N Reads Blog

Customer Reviews